US FDA Presents 3D Printing Scenarios To Spark Discussion, Lead To Future Guidance

The agency recently published a paper to spark discussions in the medtech industry on how to best regulate 3D printing of medical devices at points of care such a clinics and hospitals.

• Source: US Food and Drug Administration

More from Digital Technologies

More from Medtech Insight